Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Vertex Pharmaceuticals, Inc.
(NQ:
VRTX
)
77.87
USD
-0.93 (-1.18%)
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
79.07
Bid (Size)
77.87 (1200)
Ask (Size)
77.93 (400)
Prev. Close
78.80
Today's Range
77.85 - 80.42
52wk Range
38.44 - 87.47
Shares Outstanding
221,400,864
Dividend Yield
N/A
Top News
More News
Vertex Pharmaceuticals Up 77.9% Since SmarTrend Uptrend Call (VRTX)
June 18, 2013
from
Comtex SmarTrend® News Briefs
Vertex Pharmaceuticals, Inc. Moves Up In Market Cap Rank, Passing Intuit Inc
June 18, 2013
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Vertex Pharmaceuticals, Inc. (VRTX) was identified as having a larger market cap than the smaller end of...
Read More
category
Stocks
from
Market News Video
More News
Read More
MDY, VRTX, AME, GMCR: Large Outflows Detected at ETF
June 18, 2013
category
ETFs
from
ETF Channel
Jefferies Says Analysis on Elan Supports $19/Share Takeover Bid, Lifts Price Target to $19
June 18, 2013
category
ELN
,
Benzinga
,
REGN
, and 11 more.
from
Latest Articles from Benzinga.com
Vertex Completes Redemption of Convertible Senior Subordinated Notes
June 18, 2013
from
Business Wire News Releases
Advanced Treatment Methods, Significant Study Results, Conferences, and Final Study Data Releases - Research Report on Amgen, Celgene, Vertex Pharmaceuticals, MannKind, and Peregrine Pharmaceuticals
June 18, 2013
from
PR Newswire
Elan Corp (ELN) Could Be Worth $19 in a Takeout - Jefferies
June 18, 2013
from
StreetInsider.com News Articles
Commit To Purchase Vertex Pharmaceuticals At $55, Earn 13.3%
June 14, 2013
category
Dividends
from
Dividend Channel
Bio-Wire Equity Surveillance – Closing Bell 6/13/2013
June 13, 2013
category
MYGN
,
MRK
,
Bio/Wire
, and 1 more.
from
Bio-Wire.Com
Vertex Pharmaceuticals Incorporated - Trading Recap
June 13, 2013
from
AVAFIN
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.